BPC-157 TB-500 Protocol Tendon Healing: Comparison by Injury Type
Achilles Tendinopathy 500mcg daily 2.5mg 2×/week 6–8 weeks Subcutaneous, medial/lateral to tendon 4–6 weeks to pain reduction Combine with eccentric loading exercises after week 2 Rotator Cuff Partial Tear 5mg 2×/week 8 weeks Deltoid, near shoulder joint 6–8 w
This comparison does not assign a generated winner or score.
- Achilles Tendinopathy
- 500mcg daily
- 2.5mg 2×/week
- 6–8 weeks
- Subcutaneous, medial/lateral to tendon
- 4–6 weeks to pain reduction
- Combine with eccentric loading exercises after week 2
- Rotator Cuff Partial Tear
- 5mg 2×/week
- 8 weeks
- Deltoid, near shoulder joint
- 6–8 weeks to functional improvement
- Higher TB-500 dose due to poor vascular supply
- Patellar Tendinitis
- 250–500mcg daily
- 2mg 2×/week
- 4–6 weeks
- Subcutaneous, above or below patella
- 3–5 weeks to load tolerance
- Lower doses effective for smaller tendon
- Tennis Elbow (Lateral Epicondylitis)
- 250mcg daily
- 4 weeks
- Subcutaneous, over extensor tendons
- 2–4 weeks to grip strength return
- Often resolves faster than larger tendons
- Plantar Fasciitis
- 6 weeks
- Subcutaneous, medial arch of foot
- 4–6 weeks to walking tolerance
- Fascia behaves similarly to tendon tissue
- Professional Assessment
- Local injection critical for BPC-157
- Systemic TB-500 acceptable
- Minimum 4 weeks required
- Proximity <2 inches from lesion
- Conservative management takes 12–16 weeks
- Both peptides are research compounds. Not FDA-approved for clinical use